Visual function tests for early age-related macular degeneration
Part of Eyes & vision clinical trials.
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have 20/20 vision (with glasses or contacts) in both eyes.
- You have early or intermediate AMD in at least one eye, confirmed by the presence of drusen or pigment changes.
- You do not have advanced AMD (geographic atrophy or wet AMD) in either eye.
- You do not have other eye conditions like glaucoma or severe nearsightedness that could affect the tests.
- You do not have a neurological condition that would make vision testing difficult.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a quick, noninvasive eye test that measures how well you see in the dark, which can be an early sign of dry AMD. Researchers want to see if the test relates to everyday tasks like reading or driving at night.
This study looks at people with intermediate age-related macular degeneration (AMD), a common eye condition that can affect central vision. The researchers want to better understand how AMD changes over time by using different types of eye scans. This may help find ways to monitor the condition and guide future treatments.
This study uses specialized eye imaging to track changes in geographic atrophy, a type of vision loss from macular degeneration. Researchers will use new imaging techniques to better understand how this condition progresses and how treatments work.
This study uses a special camera to take pictures of the back of your eye (retina) to see how age-related macular degeneration (AMD) affects everyday activities like reading and recognizing faces. It also compares people with AMD to healthy volunteers to understand the differences.
This study uses artificial intelligence to track changes in the eyes of people with early or intermediate age-related macular degeneration (AMD). It aims to better understand how the disease progresses and may help doctors personalize care.
This study focuses on people age 50+ with early “wasting away” changes in the macula (central retina) called atrophic lesions. It aims to better understand how these early changes progress and how they affect vision testing, which may help improve future treatments.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.